Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Xtant Medical Holdings (XTNT) over the last 12 years, with Q3 2025 value amounting to $4.0 million.

  • Xtant Medical Holdings' Other Accumulated Expenses rose 9550.12% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year increase of 9550.12%. This contributed to the annual value of $2.2 million for FY2024, which is 4427.73% up from last year.
  • Per Xtant Medical Holdings' latest filing, its Other Accumulated Expenses stood at $4.0 million for Q3 2025, which was up 9550.12% from $3.8 million recorded in Q2 2025.
  • In the past 5 years, Xtant Medical Holdings' Other Accumulated Expenses ranged from a high of $4.2 million in Q1 2025 and a low of $800000.0 during Q2 2023
  • Its 5-year average for Other Accumulated Expenses is $1.8 million, with a median of $1.4 million in 2021.
  • In the last 5 years, Xtant Medical Holdings' Other Accumulated Expenses tumbled by 6146.79% in 2021 and then soared by 21304.68% in 2025.
  • Xtant Medical Holdings' Other Accumulated Expenses (Quarter) stood at $1.2 million in 2021, then fell by 11.42% to $1.0 million in 2022, then surged by 48.16% to $1.5 million in 2023, then skyrocketed by 44.28% to $2.2 million in 2024, then surged by 81.23% to $4.0 million in 2025.
  • Its Other Accumulated Expenses stands at $4.0 million for Q3 2025, versus $3.8 million for Q2 2025 and $4.2 million for Q1 2025.